Analysis of the sodium pump subunit ATP1A3 in glioma patients: Potential value in prognostic prediction and immunotherapy
In conclusion, we showed that ATP1A3 is a highly promising treatment target in GBM and the risk score is an independent prognostic factor for cancer and can be used to help guide the prediction of survival time in patients with GBM.PMID:38615384 | DOI:10.1016/j.intimp.2024.112045
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Yu-Long Lan Shuang Zou Bing Qin Xiangdong Zhu Source Type: research
More News: Allergy & Immunology | Brain | Brain Tumor | Cancer | Cancer & Oncology | Genetics | Glioma | Immunotherapy | Neurology | Sodium | Study | Training | Universities & Medical Training